preclinical white papers and articles

  1. Comprehensive Services For Ophthalmic Drug Development 2/20/2025

    To maximize bioavailability while preserving vision and maintaining the structural integrity of the eye, formulation and delivery strategies must be meticulously designed.

  2. Overview Of Triple-Negative Breast Cancer: Global Clinical Trial Landscape 1/30/2025

    Triple-Negative Breast Cancer (TNBC) requires new and innovative treatments, such as biomarker-driven therapies, to enhance precision medicine and improve patient outcomes.

  3. Oncolytic Virus Therapy: Insights Into Clinical Trial Landscape And Industry Trends 1/30/2025

    Answering questions about the potential of oncolytic virus therapies, how they integrate with combination therapies, the regulatory landscape, and how it varies globally.

  4. Oncolytic Virus Therapy: Global Clinical Trial Landscape (2024) 1/30/2025

    Addressing immunological challenges and navigating the evolving regulatory environment is critical for its successful integration into clinical practice.

  5. Triple-Negative Breast Cancer: Global Clinical Trial Landscape 1/30/2025

    With over 1,500 TNBC-focused clinical trials since 2019, research efforts into Triple-negative breast cancer (TNBC) treatments are accelerating despite challenges such as drug resistance.

  6. eCOA Best Practices For Crohn's And UC Trials 1/27/2025

    Around 200 trials annually use tools like the Crohn’s Disease Activity Index (CDAI) and Modified Mayo Score (mMS) to measure clinical remission. Implementing these in eCOA systems requires careful planning.

  7. The Future Of Clinical Trials: 2025 Outlook 1/27/2025

    Looking ahead to 2025, clinical trials will evolve with new technologies, regulatory shifts, and emerging therapies. Explore key trends shaping the future of the industry.

  8. Fit-For-Purpose Biomarker Development 1/17/2025

    Here, we highlight the essential framework of a “fit-for-purpose” biomarker development strategy, emphasizing strategic and transactional engagements with clinical research organizations.

  9. Biomarkers In Oncology Studies 1/17/2025

    Here we provide an overview of oncology biomarker development and strategic considerations.

  10. Breaking Barriers In Drug Development: Time, Trust And Putting Patients First 1/16/2025

    Unpack systemic challenges in drug development that inflate costs and delay life-saving treatments. Learn about streamlining processes, fostering patient trust, and reallocating resources efficiently.